Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Amplifon sees U.S. demand lifting revenue growth in 2024

Published 03/07/2024, 08:32 AM
Updated 03/07/2024, 09:41 AM
© Reuters.

(Reuters) - Italian hearing aid maker Amplifon expects high-single-digit growth in 2024 revenues at constant exchange rates, as its market expands in the United States and stabilises in Europe, it said on Thursday.

The group in January bought 50 shops of its Miracle-Ear business from a franchisee in the U.S., aiming to strengthen its presence in the Americas to offset slowing demand in Europe.

Shares in the Milan-based group rose more than 5% following the group's results on Thursday.

The world's largest retailer of hearing aids expects profitability to grow this year, with a recurring core profit (EBITDA) margin above 24.6%.

It posted recurring EBITDA of 155.8 million euros ($169.7 million) in the last quarter, unchanged from a year earlier, and revenues up by 6% to 615 million euros.

It pledged to return a dividend of 0.29 euros per share, also in line with last year.

Amplifon also said it ask shareholders to authorise a new buyback programme for up to 10% of its share capital after the current one expires in October. ($1 = 0.9179 euros) (This story has been corrected to specify that shops were bought from a franchisee in paragraph 2)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.